Jiangsu Gdk Biological Technology Co., Ltd (SHA:688670)
China
· Delayed Price · Currency is CNY 19.20
+0.45 (2.40%)
Mar 10, 2026, 3:00 PM CST
Jiangsu Gdk Biological Technology Company Description
Jiangsu Gdk Biological Technology Co., Ltd engages in the research, development, production, and sale of human vaccines.
The company offers quadrivalent influenza virus split vaccines. Its human vaccine products are used for the prevention of various infectious diseases, including influenza, rabies, chickenpox, herpes zoster, and pneumonia.
The company was founded in 2008 and is based in Taizhou, China.
Jiangsu Gdk Biological Technology Co., Ltd
| Country | China |
| Founded | 2008 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 449 |
| CEO | Jianhui Zhang |
Contact Details
Address: No. 12 Yujin Road Taizhou, 225300 China | |
| Phone | 86 523 8620 5860 |
| Website | gdkbio.com |
Stock Details
| Ticker Symbol | 688670 |
| Exchange | Shanghai Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE100004NR4 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Jianhui Zhang | General Manager |
| Qiang Huang | Financial Director and Accounting Supevisor |
| Jianguo Xia | Deputy GM and Director |
| Jin Zhou | Secretary to the Board |
| Bin Song | Deputy General Manager |
| Guo Xiong Tian | Deputy General Manager |
| Jing Yu Zou | Deputy General Manager |